Biopolymers as Therapeutic Adjuvants: Innovations and Advancements

Biopolymers are naturally occurring polymers that are produced by living organisms. They include proteins, nucleic acids, polysaccharides, and other biomolecules. Due to their biocompatibility, biodegradability, and low toxicity, biopolymers have gained significant attention in medicine, particularly as therapeutic agents. As a class of materials, biopolymers offer unique advantages over synthetic polymers, including the ability to interact with biological systems more naturally. Their applications span drug delivery, tissue engineering, wound healing, and gene therapy, making them essential to modern biomedical research. The historical development of biopolymers as therapeutics spans from ancient uses in traditional medicine to modern biotechnology advancements. In the 19th century, the foundation was laid with the discovery of proteins and nucleic acids. In the early 20th century, therapeutic use of proteins such as insulin and polysaccharides like heparin emerged. The mid-20th century marked the rise of nucleic acids as therapeutic agents, while the late 20th century introduced biotechnology, enabling large-scale production of biopolymerbased drugs. In the 21st century, innovations in drug delivery, gene therapy, and regenerative medicine have further advanced the use of biopolymers in treating diseases.

To foster a green environment, considerable efforts have been made to replace synthetic polymers with biodegradable materials, such as biopolymers, particularly for the development of green drug delivery systems. Biopolymers are a prominent class of functional materials with high-value applications, generated either by biological systems or derived from biological sources. Natural sources of biopolymers include plants, animals, microorganisms, and agricultural wastes. Biopolymers exhibit excellent properties, including flexibility, tensile strength, stability, reusability, and many more. Biopolymers are composed of repetitive monomers bound covalently via polymerization reaction or enzyme-catalyzed assemblies of monomeric units that occur in the biosynthetic pathway within biological systems. Biopolymers can be classified based on their source, chemical composition, functional properties, degradability, type of charges, and other factors. The extraction of biopolymers involves a range of chemical and enzymatic processes that vary specifically for each biopolymer. Some of the extraction methods include the use of coagulating agents, hydrolysis, alkali and acid treatments, bleaching, deproteination, and demineralization, among others. Following extraction, purification, and often modification, biopolymers are prepared for potential applications. Due to their renewability, abundance, biodegradability, and unique properties, such as higher absorption capabilities and ease of functionalization, biopolymers have been explored for various industrial applications. This chapter examines the sources, chemistry, and extraction procedures for several important biopolymers, including polyhydroxyalkanoates, polylactic acid, chitosan, alginate, polyesteramide, starch, gelatin, polyglycolic acid, and pectin, as well as their biomedical applications.

Biopolymers are naturally occurring macromolecules, such as proteins, nucleic acids, and polysaccharides, which are produced by living organisms. Over time, interest developed in both their natural synthesis and various synthetic pathways due to their importance in a variety of applications. Enzymatic reactions within organisms synthesize biopolymers through intricate biochemical processes known as natural biosynthesis. Nowadays, microbes may be engineered to produce unique biopolymers with specialized functions, indicating developments in synthetic biology. Moreover, synthetic variations that retain desirable capabilities can be carried out by using chemical synthesis techniques to mimic the architectures of genuine biopolymers. The combination of biopolymers with clay can enhance mechanical properties, leading to the development of new materials known as biopolymer–clay nanocomposites. These nanocomposites may represent a significant innovation in the development of biopolymers with enhanced features. The functionality of biopolymers depends on their features, which include good mechanical properties, biocompatibility, and biodegradability. These features facilitate their use in areas ranging from environmental sustainability to medicine. For example, polylactic acid (PLA) is a well-known artificial biopolymer that is being used in biomedical equipment and packaging because of its strength and biodegradability. As research advances, biopolymers are becoming increasingly attractive as alternatives to traditional petroleum-based materials, addressing environmental challenges and enabling innovative solutions across diverse industries. 

Biopolymers have become apparent as a potential therapeutic material, which shows an important role in treating different diseases like cancer, neurological disorders, cardiovascular disorders, infectious diseases, diabetes, and drug delivery. Due to its biocompatible and biodegradable properties, it is widely used for therapeutic purposes. This chapter provides detailed information regarding the pharmacokinetic and pharmacodynamic properties of biopolymers. It involves a comprehensive analysis of how these materials are involved in drug absorption, distribution, metabolism, excretion, and their interaction with physiological systems. The pharmacokinetic properties of biopolymers depend on various factors such as molecular weight, degradation behavior, and structure of biopolymers, which are important for therapeutic efficacy. On the other hand, pharmacodynamic properties provide detailed information regarding mechanisms like cellular uptake and internalization, modulation in immunological responses, and physical and chemical interactions by which these materials show therapeutic responses by targeting specific cells or tissues, extending beyond the target consequences, and receptor-associated interactions. Recent advancements in the field of biopolymers involve their utilization for specific therapeutic effects, enhancing patient compliance and outcomes, with various mechanisms of action involved for showing therapeutic responses by biopolymers mentioned in this chapter. By gathering information regarding biopolymers' pharmacokinetic and pharmacodynamic properties, this chapter aims to provide detailed information on various mechanisms involving the effectiveness and efficacy of biopolymer-based therapeutics in clinical utilization.

 Applications of nanotechnology have increased the importance of research and nanocarriers, which have revolutionized medication delivery in recent years to treat a range of diseases, including cancer. Due to its multidrug resistance to several chemotherapeutic treatments, cancer, one of the most dangerous diseases in the world, has drawn the attention of experts. Scientists have created a different way to deliver chemotherapeutic drugs to the desired location while reducing side effects and enhancing delivery efficacy on healthy cells by incorporating them into nanocarriers such as synthetic polymers, nanotubes, micelles, dendrimers, magnetic nanoparticles, Quantum Dots (QDs), lipid nanoparticles, nano-biopolymeric substances, etc. Nanotechnology applications have made research and nanocarriers—which have recently transformed drug delivery to treat a variety of illnesses, including cancer—even more crucial. One of the most deadly illnesses in the world, cancer, has caught the attention of scientists because of its multidrug resistance to several chemotherapeutic therapies. By integrating chemotherapeutic drugs into nanocarriers like synthetic polymers, nanotubes, micelles, dendrimers, magnetic nanoparticles, Quantum Dots (QDs), lipid nanoparticles, nano-biopolymeric substances, etc., researchers have developed an alternative method of delivering these medications to the intended site while minimizing side effects and improving delivery efficacy on healthy cells. Preclinical and clinical research on cancer treatment has yielded promising results. Biopolymers stand out as viable options for anticancer nano drug delivery systems due to their exceptional biocompatibility. Moreover, the presence of ligands in some biopolymers that are naturally present on the surface of human cells enables active targeting.

Nano-based biopolymers are emerging as a powerful tool in targeted disease therapy, offering a promising combination of the precision of nanotechnology and the biocompatibility of natural polymers. In administering therapeutic chemicals specifically to certain disease areas, these nanoscale (1–100 nm) materials are intended to maximize therapeutic effectiveness while decreasing systemic adverse reactions. The integration of biopolymers, which are biodegradable and non-toxic, with nanoparticles allows for the creation of advanced drug delivery systems capable of responding to specific biological signals. This book chapter covers almost all current evolutions in nanomaterial-based medicament delivery techniques, with a focus on biopolymers such as polysaccharides (chitosan, alginate, cellulose, and starch) and proteins (albumin, collagen, gelatin, and silk fibroin). In cancer therapy, nano-based biopolymers can deliver chemotherapeutic agents precisely to tumour cells, minimizing damage to good tissues and overcoming the possible adverse effects linked with traditional radiation therapy. Additionally, these materials can be used for diagnostic purposes, enhancing imaging methods such as CT or MRI scans to better locate or characterize tumors. Regarding gene therapy, biopolymer-based nanoparticles can transfer genetic material, such as RNA or DNA, directly to specific cells, offering potential treatments for genetic disorders by correcting or silencing defective genes. Infectious diseases also benefit from this technology, with nano-based biopolymers delivering antimicrobial agents directly targeted to the site of infection, thereby increasing the drug's local concentration and efficacy. Furthermore, because these materials may carry antiinflammatory medications straight to inflammatory tissues, they are being investigated for the treatment of inflammatory illnesses like rheumatic arthritis, which would lessen systemic protection against the negative effects. The possibilities of nano-based biopolymers in personalized medicine are examined in this chapter, along with issues including stability, scalability, and regulatory compliance.

The application of AI within biopolymer engineering is a monumental step in the advancement of drug delivery systems. With the aid of AI, it is possible for researchers to design and develop biopolymer materials to the highest degree, which means that drug effects, targeting accuracy, and treatment modulation for each patient can be improved to a large extent, which brings out the concept of personalized medicine. This chapter presents the state-of-the-art knowledge concerning the topic of biopolymer engineering utilizing AI, with a focus on Nanomedicine and Drug Delivery, respectively, in the context of the most fundamental and interesting areas–drug delivery and therapy and Machine Learning for Polymer Design. The developing frontiers of AI and biopolymer technology have the potential to alter drug discovery, delivery and administration processes with the patient in mind, leading to better compliance and control of the remedy for the patient.

Biopolymers have emerged as a crucial component in advanced drug delivery systems due to their low toxicity, biodegradability, and inherent biocompatibility. Their ability to respond to specific stimuli or enzymes offers enhanced control over the release of therapeutic agents, making them highly valuable in precision medicine. Stimuli-triggered systems utilize external or internal signals such as pH, magnetic fields, temperature, redox potential, and light to precisely control drug release at targeted sites. For example, pH-sensitive biopolymers can release drugs in the acidic environment of tumors, while temperature-responsive systems adapt to local heat variations in tissues. This method ensures efficient drug delivery while minimizing side effects by targeting specific diseased areas. Enzyme-activated systems, on the other hand, rely on the presence of specific enzymes in the body to trigger the degradation of biopolymers and release the encapsulated drugs. These systems are beneficial in diseases such as cancer or infections, where overexpressed enzymes can be exploited for localized drug delivery. Biopolymers such as chitosan, dextran, alginate, and hyaluronic acid have been widely used in these enzyme-responsive systems, showing promising results in selective drug release. The precision and adaptability of biopolymer-based systems provide numerous benefits, including reduced systemic toxicity, controlled drug release, and enhanced therapeutic efficacy. However, challenges such as ensuring the stability of biopolymers in physiological conditions and scaling up production remain key obstacles. Ongoing research into novel biopolymers and more specific response mechanisms continues to push the boundaries of personalized medicine. Overall, biopolymer-based delivery systems signify a cutting-edge approach to achieving precise and controlled therapeutic interventions. 

Natural materials such as wood, shells, fungi, bacteria, and plants can be used to make biopolymer nanofibers (BPNFs), which are natural polymeric materials. Nanofibers (NFs) are the class of nanostructured materials that are widely used in tissue engineering (TE) and regenerative medicine (RM). These biomaterials aim to promote bone tissue regeneration at the defect location, whereupon they will eventually degrade naturally and be replaced by freshly produced bone tissue. Nanocomposite biomaterials are a relatively new class of materials that combine readily resorbable, bioactive fillers that are nanoscale in size with biopolymeric and biodegradable matrix architectures. The biocompatibility, tissue regeneration, and incorporation of nanomaterials have been assessed with alginate, fucoidan, chitosan (CS), collagen (Col), cellulose, and silk fibroin (SF). Examples of synthetic polymer-based nanocomposites in this chapter include polyethylene glycol (PEG), polycaprolactone (PCL), poly (lactic-co-glycolic) acid (PLGA), poly (lactic acid) (PLA), and polyurethane (PU) based nanocomposites. In bone tissue regeneration research, a wide range of nanofillers are used, such as graphene oxide (GO), nano titanium dioxide (nTiO2 ), nano silica (nSi), nano zirconia (nZr), nano-hydroxyapatite (nHA), and nano silver nanoparticles (AgNPs). Biopolymer-based nanofibers have unique properties that replicate the extracellular matrix (ECM) of natural tissues, making them a promising tool for tissue engineering. These nanofibers, which can be made from synthetic or natural biopolymers, have customizable mechanical properties, biocompatibility, and biodegradability, making them ideal scaffolding materials for tissue regeneration. Cell attachment, proliferation, and differentiation are essential for the successful use of nanofibers in tissue engineering applications because of their high surface area-tovolume ratio. Further improving the functionality of biopolymer-based nanofibers and encouraging targeted tissue regeneration and healing is the addition of growth factors, medications, and bioactive compounds. The latest developments in biopolymer-based nanofibers for tissue engineering emphasize their properties, techniques of production and uses in the regeneration of various tissues, such as skin, bone, cartilage, and neural tissues. The necessity for multidisciplinary research to enhance nanofiber-based scaffolds for therapeutic applications is highlighted by the exploration of the possible obstacles and future prospects in this quickly developing sector. This chapter discusses a few biomaterials that have the potential to regenerate bone tissue in the form of polymeric nanocomposites.

Bone regeneration and replacement are always challenging conditions, and with treatments, the chances of falling are often the least than expectations. This chapter emphasizes the function of biopolymers in bone replacement and regeneration, highlighting biopolymers that can be converted into scaffolds, hydrogels, and composites that mimic the extracellular matrix, facilitating the growth and repair of new bone. Their ability to promote cell adhesion, proliferation (rapid increase in the number or amount of cells), and differentiation makes them an alternative to traditional synthetic materials. Also, the biopolymer-based materials can be arranged in such a manner as to release bioactive molecules, enhancing osteogenesis,a genetic or heritable disease in which bones fracture or break easily, often without any major reason or minor injury. Angiogenesis is the process by which the body creates new capillaries from existing blood vessels. This chapter describes biopolymers in-depth and their role in the current biopolymer-based strategies for bone regeneration and replacement, including their mechanical properties, degradation rates, and osteoconductive potentials. It also focuses on the potential of biopolymers of composites and hybrid materials to enhance the regeneration the bones, combining the benefits of natural and synthetic materials. This chapter examines the potential of biopolymers for developing innovative solutions for bone replacement and regeneration, such as 3D-printed biopolymer-based implants and bioactive coatings. By harnessing the potential of biopolymers, the researchers can develop revolutionary treatments for bone regeneration and replacements, which lead to improvement in patient outcomes and enhances quality of life.

Autoimmune disorders result from dysregulated immune responses directed against the body's tissues; immunotherapeutic biopolymers are becoming increasingly important as transformational agents in this regard. These biopolymers, which comprise organic materials like peptides and polysaccharides, function in different ways to help the immune system's restoration to equilibrium. A noteworthy method pertains to the control of immune cell function, wherein biopolymers augment the functionalities of regulatory T cells while inhibiting the generation of pro-inflammatory cytokines. Furthermore, certain biopolymers, such as hyaluronic acid and chitosan, have anti-inflammatory qualities that are vital in lowering tissue damage and inflammation linked to autoimmune diseases. By influencing the gut microbiota, which has been linked to the etiology of several autoimmune disorders, these biopolymers can also balance the immune system. The adaptability of immunotherapeutic biopolymers is further demonstrated by their capacity to target particular pathways, such as the NFκB signaling cascade and cytokine production. Recent developments in nanotechnology have made it possible to create delivery systems based on biopolymers that improve the bioavailability and effectiveness of medicinal drugs. Not only does this novel method increase therapeutic specificity, but it also reduces systemic adverse effects that are frequently linked to traditional medications. Personalized and efficient therapy techniques might transform the management of autoimmune diseases as research advances and immunotherapeutic biopolymers are incorporated into clinical practice.